GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Taiwan Biomateiral Co Ltd (ROCO:6649) » Definitions » Capital Expenditure

Taiwan Biomateiral Co (ROCO:6649) Capital Expenditure : NT$-4.15 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Taiwan Biomateiral Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Taiwan Biomateiral Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was NT$-1.35 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-4.15 Mil.


Taiwan Biomateiral Co Capital Expenditure Historical Data

The historical data trend for Taiwan Biomateiral Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Biomateiral Co Capital Expenditure Chart

Taiwan Biomateiral Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -90.16 -149.39 -29.70 -37.48 -3.21

Taiwan Biomateiral Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.41 -1.58 -0.79 -0.43 -1.35

Taiwan Biomateiral Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-4.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taiwan Biomateiral Co (ROCO:6649) Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Shengyi Road, 1st Floor, No. 188, Hsinchu County, Zhubei, TWN, 302
Taiwan Biomateiral Co Ltd is an applied technology Research and Development Institute in Taiwan. It is engaged in the research and development and sales of implantable medical devices. The company's products include Foamagen, stroke interventional treatment devices.

Taiwan Biomateiral Co (ROCO:6649) Headlines

No Headlines